07:00 , Aug 23, 2004 |  BioCentury  |  Finance

Follow the money

It's no secret that financing rounds - either public or private - on average are larger in the U.S. than elsewhere. Last week saw two ex-U.S. companies move to tap into the capital available in...
07:00 , Aug 19, 2004 |  BC Extra  |  Financial News

Point Biomedical raises $27.1M

Imaging company Point Biomedical (San Carlos, Calif.) raised $27.1 million in a private round. Point will use the funds to submit an NDA for its CardioSphere ultrasound imaging agent to assess myocardial perfusion in patients...
07:00 , Apr 8, 2002 |  BioCentury  |  Finance

Ebb & Flow

The antipathy of the public markets for biotech hasn't hurt venture rounds, where investors have more savvy and take a long-term view. But while European venture capitalists have embraced the idea that building larger companies...
08:00 , Apr 5, 2002 |  BC Extra  |  Financial News

Point Biomedical raises $23.3 million

Point Biomedical (San Carlos, Calif.) raised $23.3 million in a venture financing. Investors included Invesco Private Capital; Anvers; Fininvest; General Electric Capital; Oakwood Medical Investors; S.R. One; CHL Medical Partners; De Novo Ventures; Frazier &...